Revenue: The sum of all revenue fields included for a company's operating activities.
Aclaris Therapeutics, Inc. (ACRS) had Revenue of $17.57M for the most recently reported fiscal quarter, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
$17.57M |
$-1.49M |
|
$6.43M |
|
$11.14M |
|
$21.62M |
|
$-4.05M |
|
$2.19M |
|
$-1.86M |
|
$-1.86M |
|
$-1.49M |
|
$-1.49M |
|
$-1.49M |
|
$-1.49M |
|
$-4.05M |
|
$-3.82M |
|
69.81M |
|
69.81M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$128.86M |
|
$1.62M |
|
$68.55M |
|
$197.41M |
|
$30.95M |
|
-- |
|
$9.27M |
|
$40.23M |
|
$157.18M |
|
$156.91M |
|
$157.18M |
|
70.89M |
|
| Cash Flow Statement Financials | |
$-78.33M |
|
$46.22M |
|
$26.71M |
|
$45.28M |
|
$39.88M |
|
$-5.40M |
|
$20.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
63.41% |
|
-23.03% |
|
-23.03% |
|
-- |
|
-10.57% |
|
-8.49% |
|
$-79.63M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
58.96 |
|
1.53 |
|
-0.95% |
|
-0.95% |
|
-0.76% |
|
-0.95% |
|
$2.22 |
|
$-1.14 |
|
$-1.12 |
|